Issue 2, 2015

Cytotoxic peptide conjugates of dinuclear areneruthenium trithiolato complexes

Abstract

In order to improve the water-solubility of dinuclear thiolato-bridged arene ruthenium complexes, a new series was synthesized by conjugating octaarginine, octalysine, and cyclo[Lys-Arg-Gly-Asp-D-Phe] using chloroacetyl thioether (ClAc) ligation, resulting in cytotoxic conjugates against A2780 human ovarian cancer cells (IC50 = 2–8 μM) and against the cisplatin resistant line A2780cisR (IC50 = 7–15 μM). These metal complexes represent, to the best of our knowledge, the most cytotoxic ruthenium bioconjugates reported so far.

Graphical abstract: Cytotoxic peptide conjugates of dinuclear arene ruthenium trithiolato complexes

Supplementary files

Article information

Article type
Concise Article
Submitted
26 Sep 2014
Accepted
11 Nov 2014
First published
12 Nov 2014

Med. Chem. Commun., 2015,6, 347-350

Author version available

Cytotoxic peptide conjugates of dinuclear arene ruthenium trithiolato complexes

F. Giannini, M. Bartoloni, L. E. H. Paul, G. Süss-Fink, J. Reymond and J. Furrer, Med. Chem. Commun., 2015, 6, 347 DOI: 10.1039/C4MD00433G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements